619 related articles for article (PubMed ID: 26861297)
1. Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy.
Lai YD; Wu YY; Tsai YJ; Tsai YS; Lin YY; Lai SL; Huang CY; Lok YY; Hu CY; Lai JS
Int J Mol Sci; 2016 Feb; 17(2):214. PubMed ID: 26861297
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting angiogenesis with human single-chain variable fragment antibody targeting VEGF.
Hosseini H; Rajabibazl M; Ebrahimizadeh W; Dehbidi GR
Microvasc Res; 2015 Jan; 97():13-8. PubMed ID: 25250517
[TBL] [Abstract][Full Text] [Related]
3. Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity.
Lu D; Shen J; Vil MD; Zhang H; Jimenez X; Bohlen P; Witte L; Zhu Z
J Biol Chem; 2003 Oct; 278(44):43496-507. PubMed ID: 12917408
[TBL] [Abstract][Full Text] [Related]
4. Affinity maturation and fine functional mapping of an antibody fragment against a novel neutralizing epitope on human vascular endothelial growth factor.
Lamdan H; Gavilondo JV; Muñoz Y; Pupo A; Huerta V; Musacchio A; Pérez L; Ayala M; Rojas G; Balint RF; Larrick JW
Mol Biosyst; 2013 Aug; 9(8):2097-106. PubMed ID: 23702826
[TBL] [Abstract][Full Text] [Related]
5. Potent anti-angiogenesis and anti-tumor activity of a novel human anti-VEGF antibody, MIL60.
Yang J; Wang Q; Qiao C; Lin Z; Li X; Huang Y; Zhou T; Li Y; Shen B; Lv M; Feng J
Cell Mol Immunol; 2014 May; 11(3):285-93. PubMed ID: 24608894
[TBL] [Abstract][Full Text] [Related]
6. Phage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-C block its interaction with VEGF receptor-2 and 3.
Rinderknecht M; Villa A; Ballmer-Hofer K; Neri D; Detmar M
PLoS One; 2010 Aug; 5(8):e11941. PubMed ID: 20689828
[TBL] [Abstract][Full Text] [Related]
7. Phage-derived fully human antibody scFv fragment directed against human vascular endothelial growth factor receptor 2 blocked its interaction with VEGF.
Zhang J; Li H; Wang X; Qi H; Miao X; Zhang T; Chen G; Wang M
Biotechnol Prog; 2012 Jul; 28(4):981-9. PubMed ID: 22581629
[TBL] [Abstract][Full Text] [Related]
8. Identification and in vitro characterization of phage-displayed VHHs targeting VEGF.
Farajpour Z; Rahbarizadeh F; Kazemi B; Ahmadvand D; Mohaghegh M
J Biomol Screen; 2014 Apr; 19(4):547-55. PubMed ID: 24297044
[TBL] [Abstract][Full Text] [Related]
9. Tetanus Neurotoxin Neutralizing Antibodies Screened from a Human Immune scFv Antibody Phage Display Library.
Wang H; Yu R; Fang T; Yu T; Chi X; Zhang X; Liu S; Fu L; Yu C; Chen W
Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626445
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel neutralizing single-chain antibodies against vascular endothelial growth factor receptor 2.
Erdag B; Balcioglu BK; Bahadir AO; Serhatli M; Kacar O; Bahar A; Seker UO; Akgun E; Ozkan A; Kilic T; Tamerler C; Baysal K
Biotechnol Appl Biochem; 2011; 58(6):412-22. PubMed ID: 22172104
[TBL] [Abstract][Full Text] [Related]
11. A nanobody directed to a functional epitope on VEGF, as a novel strategy for cancer treatment.
Farajpour Z; Rahbarizadeh F; Kazemi B; Ahmadvand D
Biochem Biophys Res Commun; 2014 Mar; 446(1):132-6. PubMed ID: 24569074
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human leukemia in an animal model with human antibodies directed against vascular endothelial growth factor receptor 2. Correlation between antibody affinity and biological activity.
Zhu Z; Hattori K; Zhang H; Jimenez X; Ludwig DL; Dias S; Kussie P; Koo H; Kim HJ; Lu D; Liu M; Tejada R; Friedrich M; Bohlen P; Witte L; Rafii S
Leukemia; 2003 Mar; 17(3):604-11. PubMed ID: 12646950
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms.
Bedinger D; Lao L; Khan S; Lee S; Takeuchi T; Mirza AM
MAbs; 2016; 8(2):389-404. PubMed ID: 26563652
[TBL] [Abstract][Full Text] [Related]
14. Isolation of a novel neutralizing antibody fragment against human vascular endothelial growth factor from a phage-displayed human antibody repertoire using an epitope disturbing strategy.
Lamdan H; Ayala M; Rojas G; Munoz Y; Morera Y; Guirola O; Chinea G; Gavilondo JV
J Biotechnol; 2011 Jan; 151(2):166-74. PubMed ID: 21167224
[TBL] [Abstract][Full Text] [Related]
15. A humanized anti-VEGF rabbit monoclonal antibody inhibits angiogenesis and blocks tumor growth in xenograft models.
Yu Y; Lee P; Ke Y; Zhang Y; Yu Q; Lee J; Li M; Song J; Chen J; Dai J; Do Couto FJ; An Z; Zhu W; Yu GL
PLoS One; 2010 Feb; 5(2):e9072. PubMed ID: 20140208
[TBL] [Abstract][Full Text] [Related]
16. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
17. Genetic delivery of the murine equivalent of bevacizumab (avastin), an anti-vascular endothelial growth factor monoclonal antibody, to suppress growth of human tumors in immunodeficient mice.
Watanabe M; Boyer JL; Hackett NR; Qiu J; Crystal RG
Hum Gene Ther; 2008 Mar; 19(3):300-10. PubMed ID: 18324912
[TBL] [Abstract][Full Text] [Related]
18. Mimotope vaccination for epitope-specific induction of anti-VEGF antibodies.
Li W; Ran Y; Li M; Zhang K; Qin X; Xue X; Zhang C; Hao Q; Zhang W; Zhang Y
BMC Biotechnol; 2013 Sep; 13():77. PubMed ID: 24073737
[TBL] [Abstract][Full Text] [Related]
19. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Endothelial SCUBE2 (Signal Peptide-CUB-EGF Domain-Containing Protein 2), a Novel VEGFR2 (Vascular Endothelial Growth Factor Receptor 2) Coreceptor, Suppresses Tumor Angiogenesis.
Lin YC; Liu CY; Kannagi R; Yang RB
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1202-1215. PubMed ID: 29545238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]